David Daniel, VP, Signant Health
Signant Health’s senior vice president David Daniel has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sector.
Daniel was selected from a large cross-section of established professionals in the life sciences industry, and comes after he was co-awarded the 2019 ISCDD Scientific Leadership Award.
“It is a great honour to be nominated by my peers. The life sciences industry presents many difficult challenges, yet I believe the future success of clinical research lies in linking patients to research directly applicable to their concerns, which can deepen insight with clinical expertise and ultimately help secure longer and more productive lives for families and communities around the world,” said Daniel.
Prior to his role at Signant Health, Daniel served as medical director of the National Institute of Mental Health (NIMH) Neuroscience Center at Saint Elizabeth’s Hospital and as director of clinical trials for the Stanley Foundation. In addition to this, Daniel was also the founder and president of Global Learning LLC, which was acquired by United BioSource Corporation in July 2006.
“PharmaVOICE 100 recognises the most inspirational, motivational and transformational individuals throughout the life sciences industry,”said Taren Grom, editor and co-founder of PharmaVOICE.
David’s unparalleled knowledge and understanding of data quality in today’s clinical trials make him one of the most prominent and exciting technology leaders in his field, championing transformation of the industry,” he added.
Signant Health, formerly CRF Health and Bracket, provides clinical trial solutions, and is based in Philadelphia in the US.